Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, January 25, 2011 - Adenovirus 

Submission Type: BLA    Submission ID: 125296/0    Office: OVRR

Product: Adenovirus Vaccine Live Oral Type 4 and Type 7

Applicant: Teva Women's Health, Inc.

Telecon Date/Time: 25-Jan-2011 10:41 AM        Initiated by FDA? Yes

Communication Category: Information Request

Author: Helen Gemignani

Telecon Summary: Request for 24 month stability data and for Teva's definition of Date of Manufacture.

FDA Participants: Helen Gemignani

Non-FDA Participants: Valerie Mulligan
Telecon Body:

We have the following Information Request in regard to Product Dating:

  1. Please submit real time stability data for each adenovirus type to support the requested 24 month shelf life.
  2. Please specify what date you intend to use as the “Date of Manufacture” for the dating period for the final product.

Page Last Updated: 09/25/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English